484 related articles for article (PubMed ID: 19061836)
41. MYC and the control of DNA replication.
Dominguez-Sola D; Gautier J
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890833
[TBL] [Abstract][Full Text] [Related]
42. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
[TBL] [Abstract][Full Text] [Related]
44. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
[TBL] [Abstract][Full Text] [Related]
45. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
Kurbegovic A; Trudel M
Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
[TBL] [Abstract][Full Text] [Related]
46. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
[TBL] [Abstract][Full Text] [Related]
47. Ratcheting Myc.
Freie BW; Eisenman RN
Cancer Cell; 2008 Dec; 14(6):425-6. PubMed ID: 19061831
[TBL] [Abstract][Full Text] [Related]
48. Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance.
Shachaf CM; Gentles AJ; Elchuri S; Sahoo D; Soen Y; Sharpe O; Perez OD; Chang M; Mitchel D; Robinson WH; Dill D; Nolan GP; Plevritis SK; Felsher DW
Cancer Res; 2008 Jul; 68(13):5132-42. PubMed ID: 18593912
[TBL] [Abstract][Full Text] [Related]
49. Functions of myc:max in the control of cell proliferation and tumorigenesis.
Hurlin PJ; Dezfouli S
Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
[TBL] [Abstract][Full Text] [Related]
50. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegué E; Tang F; Folkman J; Felsher DW
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16266-71. PubMed ID: 17056717
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
52. Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation.
Myant K; Qiao X; Halonen T; Come C; Laine A; Janghorban M; Partanen JI; Cassidy J; Ogg EL; Cammareri P; Laiterä T; Okkeri J; Klefström J; Sears RC; Sansom OJ; Westermarck J
Cell Rep; 2015 Aug; 12(6):1019-31. PubMed ID: 26235622
[TBL] [Abstract][Full Text] [Related]
53. Myc's secret life without Max.
Gallant P; Steiger D
Cell Cycle; 2009 Dec; 8(23):3848-53. PubMed ID: 19887915
[TBL] [Abstract][Full Text] [Related]
54. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
55. The myc oncogene: MarvelouslY Complex.
Oster SK; Ho CS; Soucie EL; Penn LZ
Adv Cancer Res; 2002; 84():81-154. PubMed ID: 11885563
[TBL] [Abstract][Full Text] [Related]
56. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.
Sun XX; He X; Yin L; Komada M; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3734-9. PubMed ID: 25775507
[TBL] [Abstract][Full Text] [Related]
57. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
58. Mediation of c-Myc-induced apoptosis by p53.
Hermeking H; Eick D
Science; 1994 Sep; 265(5181):2091-3. PubMed ID: 8091232
[TBL] [Abstract][Full Text] [Related]
59. p53 and p73 in suppression of Myc-driven lymphomagenesis.
Griesmann H; Schlereth K; Krause M; Samans B; Stiewe T
Int J Cancer; 2009 Jan; 124(2):502-6. PubMed ID: 18942718
[TBL] [Abstract][Full Text] [Related]
60. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
